Noninvasive ventilation (NIV) was originally used to treat neuromuscular disease. But new evidence now strongly supports the use of NIV to treat patients with advanced COPD.1
Recently, NIV usage has increased in hospitals to treat COPD exacerbations, which can be difficult for the patient, and costly to healthcare systems worldwide.2,3
But, when patients are discharged, they are often armed only with oxygen, medication, and an inhaler. While these measures can suffice for some patients, others require more to keep them healthy at home.
This is where the addition of home mechanical ventilation or non-invasive ventilation comes into play.
A new study supported by funding and product by Philips Respironics and ResMed found unprecedented benefits in using home oxygen therapy (HOT) in addition to home mechanical ventilation (HMV) in patients with COPD and chronic hypercapnia.4
Let’s take a closer look at the study and what it means for your practice.